<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-939
Date of Submission: 2025-01-25

This report was submitted by a Patient from Walker-Palmer Medical Center concerning patient ANON-PX-2455. The subject is a 31-year-old other with a significant medical history including seasonal allergies, migraines, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Oral route at a dosage of 472mg, initiated on 2024-12-06 for Neuropathic pain and discontinued on 2025-01-07.

On approximately 2024-12-10, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Somnolence. The Dizziness was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Somnolence was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Nice tree build seat. Citizen husband bed source here maybe. View walk sport.</data>
report_id: ADR-2025-939
report_date: '2025-01-25'
patient_details:
  patient_id: ANON-PX-2455
  gender: Other
  relevant_history:
  - seasonal allergies
  - migraines
  - anxiety
  age_at_reaction: 31
suspected_drugs:
- drug_name: Gabapentin
  dosage: 472mg
  route_of_administration: Oral
  start_date: '2024-12-06'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2025-01-07'
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-12-10'
  severity: Mild
  outcome: Recovered
  intervention_required: false
- symptom_name: Somnolence
  onset_date: '2024-12-10'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Positive rechallenge
  naranjo_score: 9
reporting_facility: Walker-Palmer Medical Center
reporter_type: Patient
notes: Nice tree build seat. Citizen husband bed source here maybe. View walk sport.
